Substance abuse and psychiatric illness: Treatment experience

被引:6
|
作者
Sloan, KL [1 ]
Rowe, G [1 ]
机构
[1] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
来源
关键词
D O I
10.3109/00952999809019609
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
The purpose of this paper is to describe an outpatient dual-diagnosis treatment program and 1-year clinical outcome and hospital utilization data. Subjects were 118 consecutive admissions to the Seattle Veterans Affairs (VA) Medical Center's Dual Disorders program over the period from June 1, 1992, to August 31, 1994. Program eligibility requirements included having a current substance use disorder and an active non-substance-related major Axis I disorder (typically major depression, post-traumatic stress disorder [PTSD], bipolar disorder, or schizoaffective disorder). The treatment frame involved group-based programming (including support, medications management, and psychoeducation), routine urine drug screening, and crisis interventions. Results showed that subjects averaged 1.5 non-substance-related Axis I psychiatric disorders (54% involving psychotic symptoms) and 1.8 active substance use disorders. Patients stayed engaged in treatment for a median of 217 days, with 60% of patients having no positive drug screens, and the overall sample having a 40% reduction in the number of inpatient bed days in the year after intake. Conclusions were that, for a number of patients with comorbid disorders, psychiatric stabilization and cessation of substance use can be ac complished within an outpatient treatment frame that averages two completed clinical contacts per week.
引用
收藏
页码:589 / 601
页数:13
相关论文
共 50 条
  • [21] Offenders With Substance Abuse Who Receive Mandatory Psychiatric Treatment
    Wu, Pei-Chuan
    Chou, Yu-Ching
    Yeh, Hui-Wen
    Huang, San-Yuan
    Cheng, Li-Hsiang
    Kao, Yu-Chen
    Chang, Hsin-An
    Tzeng, Nian-Sheng
    JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW, 2017, 45 (03):
  • [22] CONTROLLING TREATMENT COSTS OF SUBSTANCE ABUSE AND PSYCHIATRIC-PROBLEMS
    PEARSON, JM
    PERSONNEL, 1989, 66 (10) : 12 - &
  • [23] Retention in substance abuse treatment - Role of psychiatric symptom severity
    Ross, HE
    Cutler, M
    Sklar, SM
    AMERICAN JOURNAL ON ADDICTIONS, 1997, 6 (04): : 293 - 303
  • [24] Evaluating treatment environments: the quality of psychiatric and substance abuse programs
    Gossop, M
    ADDICTION, 1998, 93 (04) : 608 - 609
  • [25] Comorbid Psychiatric and Substance Abuse Disorders: Recent Treatment Research
    Riggs, Paula
    Levin, Frances
    Green, Alan I.
    Vocci, Frank
    SUBSTANCE ABUSE, 2008, 29 (03) : 51 - 63
  • [26] Which factors influence psychiatric diagnosing in substance abuse treatment?
    Rolf Wynn
    Anne Landheim
    Ellen Hoxmark
    International Journal of Mental Health Systems, 7
  • [27] Which factors influence psychiatric diagnosing in substance abuse treatment?
    Wynn, Rolf
    Landheim, Anne
    Hoxmark, Ellen
    INTERNATIONAL JOURNAL OF MENTAL HEALTH SYSTEMS, 2013, 7
  • [28] INPATIENT TREATMENT OF ADOLESCENTS WITH PSYCHIATRIC AND SUBSTANCE-ABUSE DISORDERS
    KAMINER, Y
    FRANCES, RJ
    HOSPITAL AND COMMUNITY PSYCHIATRY, 1991, 42 (09): : 894 - 896
  • [29] Comorbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans
    Khan, Uzma A.
    Mcginnis, Kathleen
    Skanderson, Melissa
    Butt, Adeel
    GASTROENTEROLOGY, 2007, 132 (04) : A163 - A163
  • [30] Comorbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans
    Khan, U. A.
    McGinnis, K.
    Skanderson, M.
    Butt, A. A.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S208 - S208